Hypersensitivity to nadroparin calcium: Case report and review of the literature

Clinical Drug Investigation

Volumn 24, Issue 7, 2004, Pages 421-426

  Ebo, Didier G ^a   Haine, Steven E ^a   Hagendorens, Margo M ^a   Bridts, Chris H ^a   Conraads, Viviane M ^a   Vorlat, Ann ^a   Vrints, Chris J ^a   De Clerck, Luc S ^a   Stevens, Wim J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; DRUG WITHDRAWAL; ECZEMA; EOSINOPHILIA; HEART CATHETERIZATION; HUMAN; HYPERSENSITIVITY; INJECTION SITE; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 3242737283     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424070-00005     Document Type: Review

References (73)

1. Hirsh J, Warkentin TE, Raschke R, et al. Heparin and low molecular weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998; 114: S489-510
2. Kleinschmidt K, Charles R. Pharmacology of low molecular weight heparins. Emerg Med Clin North Am 2001; 19: 1025-49
3. Hirsh J, Anand SS, Halperin JL, et al. Guide to anticoagulant therapy: Heparin: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 103: 2994-3018
4. White PW, Sadd JR, Nensel RE. Thrombotic complications of heparin therapy including six cases of heparin-induced skin necrosis. Ann Surg 1979; 190: 595-608
5. Levine LE, Bernstein JE, Soltani K, et al. Heparin-induced cutaneous necrosis unrelated to injection sites: a sign of potentially lethal complications. Arch Dermatol 1983; 119: 400-3
6. Platell CF, Tan EG. Hypersensitivity reactions to heparin: delayed onset thrombocytopenia and necrotizing skin lesions. Aust N Z J Surg 1986; 56: 621-3
7. Stricker H, Lammle B, Furlan M, et al. Heparin-dependent in vitro aggregation of normal platelets by plasma of a patient with heparin-induced skin necrosis: specific diagnostic test for a rare side effect. Am J Med 1988; 85: 721-4
8. Mureebe L, Silver D. Heparin-induced thrombocytopenia: pathophysiology and management. Vasc Endovascular Surg 2002; 36: 163-70
9. Eikelboom JW, Hankey GJ. Low molecular weight heparins and heparinoids. Med J Aust 2002; 177: 379-83
10. Rice L, Nguyen PH, Vann AR. Preventing complications in heparin-induced thrombocytopenia: alternative anticoagulants are improving patient outcomes. Postgrad Med 2002; 112: 85-9
11. Zimmermann R, Harenberg J, Weber E, et al. Treatment in a heparin-induced skin reaction with a low-molecular heparin analog [in German]. Dtsch Med Wochenschr 1984; 109: 1326-8
12. Rajka G, Skog E. On the question of heparin hypersensitivity. Acta Derm Venereol 1962; 42: 27-34
13. Bernstein IL. Anaphylaxis to heparin sodium. JAMA 1956; 161: 1379-81
14. Zinn WJ. Side reactions to heparin in clinical practice. Am J Cardiol 1964; 14: 36-8
15. O'Toole RD. Heparin: adverse reaction [letter]. Ann Intern Med 1973; 79: 759
16. Hancock BW, Naysmith A. Hypersensitivity to chlorocresol-preserved heparin. BMJ 1975; 3: 746-7
17. Bloom B, Chalmers PC, Danker PR, et al. Cardiovascular collapse and refractory bronchospasm following administration of vancomycin, esmolol, and heparin. J Cardiothorac Anesth 1989; 3: 748-1
18. MacLean JA, Moscicki R, Bloch KJ. Adverse reactions to heparin. Ann Allergy 1990; 65: 254-9
19. Odeh M, Oliven A. Urticaria and angioedema induced by low-molecular-weight heparin. Lancet 1992; 340: 972-3
20. Yates P, Jones S. Heparin skin necrosis: an important indicator of potentially fatal heparin hypersensitivity. Clin Exp Dermatol 1993; 18: 138-41
21. Patriarca G, Rossi M, Schiavino D, et al. Rush desensitization in heparin hypersensitivity: a case report. Allergy 1994; 49: 292-4
22. Al Eryani AY, al Momen AK, Fayed DF, et al. Successful heparin desensitization after heparin-induced anaphylactic shock. Thromb Res 1995; 79: 523-6
23. Wessel P, Grégoire F, Wessel F. L'allergie immédiate à l'héparine par voie sous-cutanée: réflexions a propos d'un cas. Rev Fr Allergol 1996; 36: 796-8
24. Smith RE, Townsend GE, Berry BR, et al. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy. Ann Pharmacother 1996; 30: 476-80
25. Harrison SJ, Rafferty I, McColl MD. Management of heparin allergy during pregnancy with danaparoid. Blood Coagul Fibrinolysis 2001; 12: 157-9
26. Bircher AJ, Fluckiger R, Buchner SA. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 1990; 123: 507-14
27. Manoharan A. Heparin-induced skin reaction with low molecular-weight heparin [letter]. Eur J Haematol 1992; 48: 234
28. Philips JK, Majumbar G, Hunt BJ, et al. Heparin-induced skin reaction due to two different preparations of low molecular weight heparin. Br J Haematol 1993; 84: 349-50
29. Rassmussen C, Skov L, Da Cunha Bang F. Delayed-type hypersensitivity to low-molecular-weight heparin. Am J Contact Dermat 1993; 4: 118-9
30. Bircher AJ, Itin PH, Tsakiris DA, et al. Delayed hypersensitivity to one low-molecular-weight heparin with tolerance of other low-molecular-weight heparins. Br J Dermatol 1995; 132: 461-3
31. Moreau A, Dompmartin A, Esnault P, et al. Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin. Contact Dermatitis 1996; 34: 31-4
32. Mendez J, Sanchis ME, de la FR, et al. Delayed-type hypersensitivity to subcutaneous enoxaparin. Allergy 1998; 53: 999-1003
33. Perdu D, Lavaud F, Salmon V, et al. Purpura vasculaire provoqué par l'injection de daltéparine. Rev Fr Allergol 1999; 39: 564-6
34. Bats BD, Rivard L, Bellemin B, et al. Leukocytoclastic vasculitis after injection of low-molecular-weight heparin [letter]. Presse Med 2000; 29: 1604
35. Figarella I, Barbaud A, Lecompte T, et al. Cutaneous delayed hypersensitivity reactions to heparins and heparinoids. Ann Dermatol Venereol 2001; 128: 25-30
36. Ebo DG, Stevens WJ, Bridts CH, et al. Latex-specific IgE, skin testing, and lymphocyte transformation to latex in latex allergy. J Allergy Clin Immunol 1997; 100: 618-23
37. Ebo DG, Lechkar B, Schuerwegh AJ, et al. Validation of a two-color flow cytometric assay detecting in vitro basophil activation for the diagnosis of IgE-mediated natural rubber latex allergy. Allergy 2002; 57: 706-12
38. Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-8
39. Greinacher A, Potzsch B, Amiral J, et al. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71: 247-51
40. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5
41. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1-7
42. Warkentin TE. Heparin-induced thrombocytopenia and its treatment. J Thromb Thrombolysis 2000; 9 Suppl. 1: S29-35
43. Pouplard C, Amiral J, Borg JY, et al. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 1997; 99: 273-80
44. Drouet M, Le Pabic F, Le Sellin J, et al. Allergy to heparin. Special problems set by pregnant women. Allergol Immunopathol (Madr) 1992; 20: 225-9
45. Dux S, Pitlik S, Perry G, et al. Hypersensitivity reaction to chlorbutol-preserved heparin [letter]. Lancet 1981; I: 149
46. Bircher AJ. The differential diagnosis of heparin-induced skin lesions [letter]. Br J Haematol 1993; 85: 837
47. O'Donnell BF, Tan CY. Delayed hypersensitivity reaction to heparin. Br J Dermatol 1993; 129: 634-6
48. Koch P, Hindi S, Landwehr D. Delayed allergic skin reactions due to subcutaneous heparin-calcium, enoxaparin-sodium, pentosan polysulfate and acute skin lesions from systemic sodium-heparin. Contact Dermatitis 1996; 34: 156-8
49. Gonzalo Garijo MA, Revenga Arranz F. Type IV hypersensitivity to subcutaneous heparin: a new case. J Investig Allergol Clin Immunol 1996; 6: 388-91
50. Hunzelmann N, Gold H, Scharffetter-Kochanek K. Concomitant sensitization to high and low molecular-weight heparins, heparinoid and pentosanpolysulfate. Contact Dermatitis 1998; 39: 88-9
51. Harenberg J, Huhle G, Wang L, et al. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG. Allergy 1999; 54: 473-7
52. Koch P, Munssinger T, Rupp-John C, et al. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin. J Am Acad Dermatol 2000; 42: 612-9
53. Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001; 27: 47-52
54. Harenberg J, Hoffmann U, Huhle G, et al. Cutaneous reactions to anticoagulants: recognition and management. Am J Clin Dermatol 2001; 2: 69-75
55. Kroon C, de Boer A, Kroon JM, et al. Influence of skinfold thickness on heparin absorption. Lancet 1991; 337: 945-6
56. Ingber A, Trattner A, Cohen IR, et al. Low doses of low molecular weight heparin in vivo inhibits the elicitation of contact hypersensitivity. Acta Derm Venereol 1994; 74: 454-6
57. Bochner BS. Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 2000; 106: S292-302
58. Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, et al. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70: 838-45
59. Metzelaar MJ, Wijngaard PL, Peters PJ, et al. CD63 antigen: a novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266: 3239-45
60. Knol EF, Mul FP, Jansen H, et al. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991; 88: 328-38
61. Sainte-Laudy J, Sabbah A, Vallon C, et al. Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry: comparison with histamine release. Inflamm Res 1998; 47: 401-8
62. Ebo DG, Piel GC, Conraads V, et al. IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine. Ann Allergy Asthma Immunol 2001; 87: 243-5
63. Ebo DG, Schuerwegh A, Stevens WJ. Anaphylaxis to starch. Allergy 2000; 55: 1098-9
64. Szolar-Platzer C, Aberer W, Kranke B. Delayed-type skin reaction to the heparin-alternative danaparoid. J Am Acad Dermatol 2000; 43: 920-2
65. Nicolie B, Bonneau JC, Le Sellin J, et al. Delayed hypersensitivity to heparins and heparinoids. Allerg Immunol (Paris) 2002; 34: 47-50
66. Prisco D, Falciani M, Antonucci E, et al. Hirudins for prophylaxis and treatment of venous thromboembolism. Semin Thromb Hemost 2001; 27: 543-9
67. Markwardt F. Hirudin as alternative anticoagulant: a historical review. Semin Thromb Hemost 2002; 28: 405-14
68. Erdmann S, Hertl M, Merk HF. Spätreaktion auf Heparine und Heparinoide-Hirudin als therapeutische Alternative. Eine Fallbeschreibung. Z Haut Geschlechtskr 1998; 73: 505-10
69. Lubenow N, Greinacher A. Hirudin in heparin-induced thrombocytopenia. Semin Thromb Hemost 2002; 28: 431-8
70. Bircher AJ, Czendlik CH, Messmer SL, et al. Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction. J Allergy Clin Immunol 1996; 98: 994-6
71. Zollner TM, Gall H, Volpel H, et al. Type IV allergy to natural hirudin confirmed by in vitro stimulation with recombinant hirudin. Contact Dermatitis 1996; 35: 59-60
72. Smith KJ, Rosario-Collazo J, Skelton H. Delayed cutaneous hypersensitivity reactions to hirudin. Arch Pathol Lab Med 2001; 125: 1585-7
73. Jappe U, Reinhold D, Bonnekoh B. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration. Contact Dermatitis 2002; 46: 29-32